Ling Mei
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 20
- Immunology top 5%
- Immune cells in cancer 6
- Genetics top 2%
- Inflammatory Bowel Disease 15
- Electrochemistry top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 37
-
- RNA Interference and Gene Delivery 15
- Advanced biosensing and bioanalysis techniques 10
-
- Advanced Nanomaterials in Catalysis 6
-
- Autophagy in Disease and Therapy 6
- Co-authors
- Zhirong ZhangQin HeHuile GaoStephan R. TarganJerome I. RotterQianyu ZhangKent D. TaylorYayuan Liu
- Cited by
- BiomaterialsImmunologyGenetics
- Journals
- Inflammatory Bowel Diseases (8 papers)Journal of Controlled Release (6 papers)Gastroenterology (5 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Ling Mei
110 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 138
- Biomaterials 897
- Immunology 664
- Genetics 717
- Electrochemistry 126
- Biomedical Engineering 895
Countries citing papers authored by Ling Mei
This map shows the geographic impact of Ling Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Mei more than expected).
Fields of papers citing papers by Ling Mei
This network shows the impact of papers produced by Ling Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Mei. The network helps show where Ling Mei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 17 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 20 | |
| 11 | 2022 | 27 | |
| 12 | 2022 | 15 | |
| 13 | 2022 | 21 | |
| 14 | 2018 | 61 | |
| 15 | 2018 | 33 | |
| 16 | 2018 | 26 | |
| 17 | 2015 | 17 | |
| 18 | 2014 | 90 | |
| 19 | 2007 | 95 | |
| 20 | 2007 | 105 |
About Ling Mei
Ling Mei is a scholar working on Biomaterials, Immunology, Physiology, Biomedical Engineering and Biotechnology, having authored 116 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (37 papers), Nanoparticle-Based Drug Delivery (20 papers), RNA Interference and Gene Delivery (15 papers), Inflammatory Bowel Disease (15 papers), Advanced biosensing and bioanalysis techniques (10 papers), Advanced Nanomaterials in Catalysis (6 papers), Autophagy in Disease and Therapy (6 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Biomaterials (897 citations), Immunology (664 citations), Genetics (717 citations), Electrochemistry (126 citations) and Biomedical Engineering (895 citations). Ling Mei has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zhirong Zhang, Qin He, Huile Gao, Stephan R. Targan, Jerome I. Rotter, Qianyu Zhang, Kent D. Taylor, Yayuan Liu, Hsiu‐O Ho and Te‐Hua Fang. Their work appears in journals such as Inflammatory Bowel Diseases, Journal of Controlled Release, Gastroenterology, ACS Applied Materials & Interfaces and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.